FDA recall D-0729-2016

Genzyme Corporation · Class II · drug

Product

Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular injection only, Rx Only, Four vials per Carton, Carton contains 2 vials of Thyrogen and 2 vials of diluent, Storage: store at 2-8 C, Genzyme Corporation, Cambridge, MA 02142, NDC 58468-1849-04.

Reason for recall

Presence of Particulate Matter: Glass particles found in the product after reconstitution.

Distribution

Nationwide, Puerto Rico and Malaysia, Taiwan, Brazil, and Israel.

Key facts

Status
Terminated
Initiation date
2016-02-16
Report date
2016-03-09
Termination date
2017-03-02
Voluntary/Mandated
Voluntary: Firm initiated
Location
Cambridge, MA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0729-2016